🔎 Trials Near Me

Hjem › KOLS › Pennsylvania › Philadelphia

Kliniske studier for KOLS i Philadelphia, PA

23 studier for KOLS søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

RekruttererFase 3
  • Research Site, Philadelphia
  • Research Site, Philadelphia
Alder 40 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Suburban Research Associates - Media- Site Number : 8400143, Media · 12 mi unna
Alder 40 til 80 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

RekruttererFase 2
  • DM Clinical Research - Philadelphia, Philadelphia
Alder 40 til 85 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07684820

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Temple University Hospital- Site Number : 8400059, Philadelphia
Alder 40 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Rekrutterer
  • Penn Medicine, Philadelphia
  • Temple University, Philadelphia
Alder 40 til 80 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2
  • Research Site, Philadelphia
  • Research Site, Philadelphia
Alder 40 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

RekruttererFase 2
  • Temple University, Philadelphia
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RekruttererFase 3
  • Research Site, Horsham · 16 mi unna
  • Research Site, Wilmington · 25 mi unna
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RekruttererFase 3
  • Research Site, Philadelphia
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06883305

COPD Exacerbation Follow Up

RekruttererObservasjonsstudie
  • Thomas Jefferson University, Philadelphia
Alder 40 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07118306

STRIVE Post-Market Registry Study

RekruttererObservasjonsstudie
  • Temple University, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RekruttererFase 3
  • GSK Investigational Site, West Chester · 24 mi unna
Alder 40 til 75 · Alle kjønn · Oppdatert 28. jul. 2026 · NCT07177339

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

Rekrutterer
  • Temple University Hospital, Philadelphia
Alder 22 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07222410

SPIROMICS Study of Early COPD Progression (SOURCE)

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Temple University, Philadelphia
Alder 30 til 55 · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05033990

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Rekrutterer
  • Temple University - Temple Lung Center, Philadelphia
Alder 40 til 80 · Alle kjønn · Oppdatert 28. apr. 2026 · NCT07051707

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Rekrutterer
  • Temple University, Philadelphia
Alder 40 til 84 · Alle kjønn · Oppdatert 24. apr. 2026 · NCT06891755

Feasibility of Semaglutide in Advanced Lung Disease

RekruttererFase 1/2
  • University of Pennsylvania Perelman School of Medicine, Philadelphia
Alder 18 til 80 · Alle kjønn · Oppdatert 21. apr. 2026 · NCT05746039

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RekruttererFase 3
  • GSK Investigational Site, Philadelphia
Alder 40 til 80 · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06961214

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

RekruttererObservasjonsstudie
  • Thomas Jefferson University, Philadelphia
Alder 50 til 80 · Alle kjønn · Oppdatert 3. mar. 2026 · NCT06974981

Supporting Evidence-based Responses to Emotional Needs in Emphysema

Rekrutterer
  • University of Pennsylvania, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jan. 2026 · NCT06600126

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

RekruttererObservasjonsstudie
  • Temple University, Philadelphia
Alder 50 og eldre · Alle kjønn · Oppdatert 5. aug. 2025 · NCT06122077

Temple Health Chest Initiative (THCI 2.0)

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Temple University Of the Commonwealth System of Higher Education, Philadelphia
Alder 50 til 80 · Alle kjønn · Oppdatert 18. apr. 2025 · NCT06933758

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Rekrutterer
  • Jeanes Hospital, Philadelphia
  • Temple University, Philadelphia
Alder 30 og eldre · Alle kjønn · Oppdatert 6. feb. 2025 · NCT05204888

KOLS-studier i andre byer

Andre studier i Philadelphia

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.